Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

BACKGROUND: The optimal anticoagulation strategy for patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement or native valve repair remains uncertain. HYPOTHESIS: We evaluated the safety and efficacy of apixaban vs warfarin in patients with AF and a history of BPV replacemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Guimarães, Patricia O., Pokorney, Sean D., Lopes, Renato D., Wojdyla, Daniel M., Gersh, Bernard J., Giczewska, Anna, Carnicelli, Anthony, Lewis, Basil S., Hanna, Michael, Wallentin, Lars, Vinereanu, Dragos, Alexander, John H., Granger, Christopher B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522998/
https://www.ncbi.nlm.nih.gov/pubmed/30907005
http://dx.doi.org/10.1002/clc.23178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522998/
https://www.ncbi.nlm.nih.gov/pubmed/30907005
http://dx.doi.org/10.1002/clc.23178

Ejemplares similares